|
市場調査レポート
商品コード
1519380
細胞分離技術市場レポート:製品タイプ、細胞タイプ、技術、用途、エンドユーザー、地域別、2024年~2032年Cell Separation Technologies Market Report by Product, Cell Type, Technology, Application, End User, and Region 2024-2032 |
||||||
カスタマイズ可能
|
細胞分離技術市場レポート:製品タイプ、細胞タイプ、技術、用途、エンドユーザー、地域別、2024年~2032年 |
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 148 Pages
納期: 2~3営業日
|
世界の細胞分離技術市場規模は2023年に104億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに339億米ドルに達し、2024年から2032年の間に13.7%の成長率(CAGR)を示すと予測しています。製薬・バイオテクノロジー分野での細胞分離技術の採用の増加、個別化医療への需要の高まり、業界における継続的な技術進歩は、市場を牽引する主な要因のいくつかを表しています。
細胞分離技術、または細胞単離技術は、不均一な混合細胞から特定の細胞を分離するために使用される様々な方法と技術を指します。標準的な技術には、マイクロ流体細胞選別、蛍光活性化細胞選別(FACS)、免疫原性細胞分離、磁気活性化細胞選別(MACS)、密度勾配構成などがあります。細胞分離技術は、希少な腫瘍細胞や幹細胞を、さらなる分析や治療目的のために分離するのに役立ちます。その結果、細胞分離技術はヘルスケアやバイオテクノロジー産業において、疾病診断、創薬、バイオプロセスなどの調査、臨床、産業用途に使用されています。さらに、細胞分離技術は、疾病メカニズムの解明や個別化医薬品の開発のための細胞不均一性の研究に不可欠です。
創薬および薬剤開発手順を強化するために製薬業界全体で細胞分離技術の利用が増加していることが、市場開拓の主な促進要因となっています。これに伴い、がん、後天性免疫不全症候群(AIDS)、嚢胞性線維症など、多くの慢性疾患や感染症の流行が拡大していることが、市場成長を後押ししています。さらに、個別化医療や再生医療に対する需要の高まりが、標的治療のために特定の細胞タイプを分離できる、特異性の高い細胞分離技術の必要性を煽っています。このほか、ヒトパピローマウイルス(HPV)、インフルエンザ、ロタウイルスなど、さまざまな疾患のワクチン製造に細胞分離技術が広く利用されていることも、同市場に有利な見通しをもたらしています。これに加えて、盛んなバイオテクノロジー分野では、新規の細胞ベースの治療法や治療法を開発するための研究開発(R&D)イニシアチブに大規模な投資が行われており、これが市場の成長に寄与しています。これと同時に、幹細胞研究への集中的な取り組み、体外診断薬に対する需要の急増、ヘルスケア・インフラを改善するために各国政府が実施している数々の有利なイニシアチブの実施が、市場の拡大を後押ししています。さらに、マイクロフルイディクス、ラボオンチップ、マイクロアレイ技術など、細胞分離技術における継続的な技術進歩が、市場に有益な成長機会をもたらしています。さらに、核酸、クロマチン、タンパク質、その他の複雑な細胞の連続的な検査を可能にする高度な分離ツールの出現は、もう一つの重要な成長促進要因として作用しています。
The global cell separation technologies market size reached US$ 10.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 33.9 Billion by 2032, exhibiting a growth rate (CAGR) of 13.7% during 2024-2032. The rising adoption of cell separation technologies across the pharmaceutical and biotechnology sectors, the growing demand for personalized medicine, and ongoing technological advancements in the industry represent some of the key factors driving the market.
Cell separation technologies, or cell isolation technologies, refer to a range of methods and techniques used to isolate specific cells from a heterogeneous mixture of cells. Some of the standard techniques include microfluidic cell sorting, fluorescence-activated cell sorting (FACS), immunogenicity cell isolation, magnetic-activated cell sorting (MACS), and density gradient configuration. Cell separation technologies help isolate rare tumor cells or stem cells for further analysis and therapeutic purposes. As a result, they are used across the healthcare and biotechnology industries for research, clinical, and industrial applications, such as disease diagnosis, drug discovery, and bioprocessing. In addition to this, cell separation technologies are essential for studying cellular heterogeneity to understand disease mechanisms and develop personalized medicines.
The increasing use of cell separation technologies across the pharmaceutical industry to enhance drug discovery and development procedures represents the primary factor driving the market growth. In line with this, the growing prevalence of numerous chronic and infectious diseases, such as cancer, acquired immune deficiency syndrome (AIDS), and cystic fibrosis, is propelling the market growth. Moreover, the increasing demand for personalized and regenerative medicines is fueling the need for highly specific cell separation technologies that can isolate specific cell types for targeted therapy. Besides this, the widespread utilization of cell separation technologies in manufacturing vaccines for various diseases, including human papillomavirus (HPV), influenza, and rotavirus, is creating a favorable outlook for the market. In addition to this, extensive investments in research and development (R&D) initiatives in the flourishing biotechnology sector for developing novel cell-based treatments and therapies are contributing to the market growth. Concurrent with this, an intensive focus on stem cell research, the surging demand for in vitro diagnostics, and the implementation of numerous favorable initiatives undertaken by governments of various countries to improve healthcare infrastructure are aiding in market expansion. Furthermore, ongoing technological advancements in cell separation technologies, such as microfluidics, lab-on-a-chip, and microarray technologies, are presenting remunerative growth opportunities for the market. Furthermore, the advent of advanced isolation tools that allows continuous examination of nucleic acids, chromatin, proteins, and other complex cells is acting as another significant growth-inducing factor.
IMARC Group provides an analysis of the key trends in each sub-segment of the global cell separation technologies market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, cell type, technology, application and end user.
Instruments
Consumables
The report has provided a detailed breakup and analysis of the cell separation technologies market based on the product. This includes instruments and consumables. According to the report, consumables represented the largest segment.
Human Cells
Animal Cells
A detailed breakup and analysis of the cell separation technologies market based on the cell type has also been provided in the report. This includes human and animal cells.
Centrifugation-based Cell Separation
Surface marker-based Cell Separation
Filtration-based Cell Separation
The report has provided a detailed breakup and analysis of the cell separation technologies market based on the technology. This includes centrifugation-based, surface marker-based, and filtration-based cell separation.
Oncology Research
Neuroscience Research
Stem Cell Research
Microbiology
Immunology Research
Others
A detailed breakup and analysis of the cell separation technologies market based on the application have also been provided in the report. This includes oncology research, neuroscience research, stem cell research, microbiology, immunology research, and others.
Research Laboratories and Institute
Biotechnology and Biopharmaceutical Companies
Cell Banks
The report has provided a detailed breakup and analysis of the cell separation technologies market based on the end user. This includes research laboratories and institute, biotechnology and biopharmaceutical companies, and cell banks. According to the report, biotechnology and biopharmaceutical companies represented the largest segment.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for cell separation technologies. Some of the factors driving the North America cell separation technologies market included the bolstering growth of the pharmaceutical industry, the rising demand for personalized medicines, and the ongoing advancements in isolation tools.
The report has also provided a comprehensive analysis of the competitive landscape in the global cell separation technologies market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Akadeum Life Sciences, Alfa Laval AB, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Corning Incorporated, Merck KGaA, Miltenyi Biotec Inc., PerkinElmer Inc., pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG, Stemcell Technologies Inc., Terumo Corporation and Thermo Fisher Scientific Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.